Automate Your Wheel Strategy on LH
With Tiblio's Option Bot, you can configure your own wheel strategy including LH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LH
- Rev/Share 161.4826
- Book/Share 101.6695
- PB 2.7557
- Debt/Equity 0.7726
- CurrentRatio 1.5044
- ROIC 0.0583
- MktCap 23236422000.0
- FreeCF/Share 15.1114
- PFCF 18.4153
- PE 30.5846
- Debt/Assets 0.3625
- DivYield 0.0103
- ROE 0.0925
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | LH | HSBC Securities | Buy | Hold | -- | $260 | July 10, 2025 |
| Initiation | LH | Redburn Atlantic | -- | Buy | -- | $276 | April 2, 2025 |
| Upgrade | LH | Citigroup | Neutral | Buy | $250 | $300 | March 4, 2025 |
| Upgrade | LH | Evercore ISI | In-line | Outperform | $260 | $265 | Jan. 7, 2025 |
| Resumed | LH | Jefferies | -- | Buy | $265 | $275 | Dec. 10, 2024 |
| Initiation | LH | Piper Sandler | -- | Neutral | -- | $235 | Oct. 1, 2024 |
News
Are Investors Undervaluing Labcorp (LH) Right Now?
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Labcorp (LH) is a Strong Value Stock
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Labcorp (LH) is a Strong Momentum Stock
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Should Value Investors Buy Labcorp (LH) Stock?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
LH vs. MMSI: Which Stock Is the Better Value Option?
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and Merit Medical (MMSI). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Why Labcorp (LH) is a Top Value Stock for the Long-Term
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Labcorp (LH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: April 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Is it the Right Time to Retain Labcorp Stock in Your Portfolio?
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
LH's growth opportunities in important specialty testing areas are robust. Expanding through strategic acquisitions is an added plus.
Read More
Here's Why Labcorp (LH) is a Strong Growth Stock
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
LH Stock to Gain From Launch of HPV and STI Self-Collection Options
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp launches self-collection options for HPV and STI testing in its PSCs.
Read More
Why Labcorp (LH) is a Top Growth Stock for the Long-Term
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.
Read More
Should Labcorp Stock Stay in Your Portfolio Right Now?
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
LH stays on investors' radar owing to its strong focus on high-growth areas and pursuing strategic acquisitions.
Read More
Here's Why Labcorp (LH) is a Strong Value Stock
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral
Labcorp® Plasma CompleteTM offers oncologists a highly sensitive and specific genomic profiling solution from a simple blood draw BURLINGTON, N.C. , Feb. 24, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma CompleteTM , a circulating tumor DNA (ctDNA)-based comprehensive genomic profiling solution for patients with advanced solid tumors.
Read More
Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold'
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Positive
Labcorp Holdings Inc., a leader in life sciences and diagnostics, is efficiently managing its financials and focusing on core strengths for long-term growth, warranting a “Hold” rating. Competitive advantages include large scale, diversified business model, strong industry relationships, and operational efficiency, driving strong revenue and margin expansion. Recent strategic initiatives like the Fortrea spin-off, Invitae acquisition, and SYNLAB stake enhance Labcorp's core business and future growth prospects.
Read More
Why Labcorp (LH) is a Top Momentum Stock for the Long-Term
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
About Labcorp Holdings Inc. (LH)
- IPO Date 1990-03-29
- Website https://www.labcorp.com
- Industry Medical - Equipment & Services
- CEO Adam H. Schechter
- Employees 60900